half life of glp 1 agonists Trends in the Development GLP-1 Receptor Best Med #2: GLP-1 Receptor
Description
Health Technology Assessment
The researchers further compared all-cause mortality, sepsis- and infection-related mortality, and mortality related to major adverse cardiovascular and cerebrovascular events between patients treated with GLP-1 receptor agonists and patients treated with DPP-4 inhibitors
Prescriptions are based on a medical evaluation and are at the providers discretion
This case highlights the serious and sometimes life-threatening risks posed by unapproved, unregulated medications
